In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report). The company’s shares closed yesterday at $104.03.

Over the past three months, shares of ZBH have gained 0.7% compared with the industry’s 4.6% growth. With the company consistently focusing on strategic market expansion and new product launches ...

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Zimmer Biomet Holdings Inc is a global leader in medical technology, specializing in designing and manufacturing orthopedic reconstructive products, including knee and hip replacements. Beyond ...

View Zimmer Biomet Holdings, Inc. (ZBH) current and estimated P/E ratio data provided by Seeking Alpha.